BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 15692252)

  • 1. New developments in diagnosis and treatment of heparin-induced thrombocytopenia.
    Lubenow N
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):407-12. PubMed ID: 15692252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-induced thrombocytopenia in intensive care patients.
    Selleng K; Warkentin TE; Greinacher A
    Crit Care Med; 2007 Apr; 35(4):1165-76. PubMed ID: 17334253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of heparin-induced thrombocytopenia.
    Keeling D; Davidson S; Watson H;
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of heparin-induced thrombocytopenia].
    Aouizerate P; Guizard M
    Therapie; 2002; 57(6):577-88. PubMed ID: 12666266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia.
    Lubenow N; Greinacher A
    Am J Cardiovasc Drugs; 2001; 1(6):429-43. PubMed ID: 14728002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of direct thrombin inhibitors in cardiovascular surgery in patients with heparin-induced thrombocytopenia.
    Greinacher A
    Semin Thromb Hemost; 2004 Jun; 30(3):315-27. PubMed ID: 15282654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of heparin-induced thrombocytopenia.
    Kouides PA; Fricke W
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):335-45. PubMed ID: 15853606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-induced thrombocytopenia and thrombosis.
    Patel VP; Bong M; Di Cesare PE
    Am J Orthop (Belle Mead NJ); 2007 May; 36(5):255-60. PubMed ID: 17571830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-induced thrombocytopenia: treatment options and special considerations.
    Dager WE; Dougherty JA; Nguyen PH; Militello MA; Smythe MA
    Pharmacotherapy; 2007 Apr; 27(4):564-87. PubMed ID: 17381384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of unsuccessful treatment of heparin-induced thrombocytopenia (HIT) with fondaparinux.
    Miranda AC; Donovan JL; Tran MT; Gore JM
    J Thromb Thrombolysis; 2012 Jan; 33(1):133-5. PubMed ID: 21947717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fondaparinux as a treatment option for heparin-induced thrombocytopenia.
    Papadopoulos S; Flynn JD; Lewis DA
    Pharmacotherapy; 2007 Jun; 27(6):921-6. PubMed ID: 17542773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Argatroban, a new antithrombotic treatment for heparin-induced thrombocytopenia application in cardiac surgery and in intensive care].
    Rozec B; Boissier E; Godier A; Cinotti R; Stephan F; Blanloeil Y
    Ann Fr Anesth Reanim; 2014; 33(9-10):514-23. PubMed ID: 25148720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management.
    Napolitano LM; Warkentin TE; Almahameed A; Nasraway SA
    Crit Care Med; 2006 Dec; 34(12):2898-911. PubMed ID: 17075368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
    Kiser TH; Jung R; MacLaren R; Fish DN
    Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The management of patients with heparin-induced thrombocytopenia].
    Pötzsch B; Madlener K
    Hamostaseologie; 2006 Jan; 26(1):22-6. PubMed ID: 16444318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of heparin-induced thrombocytopenia: a consensus statement from the Thrombosis and Haemostasis Society of Australia and New Zealand HIT Writing Group.
    Joseph J; Rabbolini D; Enjeti AK; Favaloro E; Kopp MC; McRae S; Pasalic L; Tan CW; Ward CM; Chong BH
    Med J Aust; 2019 Jun; 210(11):509-516. PubMed ID: 31155728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    Linkins LA; Dans AL; Moores LK; Bona R; Davidson BL; Schulman S; Crowther M
    Chest; 2012 Feb; 141(2 Suppl):e495S-e530S. PubMed ID: 22315270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HIT treatment in a cardiac surgery patient.
    Anna N; Boyan T; Kader MA; Catherine M; Matthias K
    Int J Cardiol; 2010 Oct; 144(3):405-7. PubMed ID: 19324432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of heparin-induced thrombocytopenia with rivaroxaban. Case report].
    Rivera O G; Corsi S O; Pavlovic J A; Aizman S A; Varas A P
    Rev Med Chil; 2017 Sep; 145(9):1213-1217. PubMed ID: 29424412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.